医疗供应链流通环节安全隐患分析——以心脏支架为例

Analysis on Healthcare Supply Chain Security Risk——The Case of Coronary Stent

本文介绍了我国心脏支架供应链运作的现状,比较了代理和直销两种销售方式,从供应链运营的角度分析了代理制销售模式下心脏支架流通环节可能出现的安全隐患,指出了监管的漏洞和控制的盲区,接着从法律法规、行业标准、成本分担结构以及机制建设等角度进一步深入探讨了隐患的成因,最后提出了应对建议,包括提高从业资质认证标准、规范运作流程、完善信息监控及问责机制等方面。

This paper introduces the present operations of stent supply chain in China.From the perspective of supply chain management,we compare the difference between direct marketing and agent distribution channel,point out the possible security risks in the supply chain which may jeopardize patients' health.And then we analyze the cause of these risks from perspectives of regulations,industry standard,cost structure,auditing mechanism and so on.At last,we propose some suggestions to reduce these risks,including raising the entry barrier for the sales agents,normalize the operations process,better construction of the information systems and responsibility tract.